Number of the records: 1
Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection
SYS 0140754 LBL 00000naa^^22^^^^^^^^450 005 20171115140104.0 100 $a 20171030d2017 m y0sloy0103 ba 101 0-
$a eng 102 $a SK 200 1-
$a Combination of LINE-1 hypomethylation and RASSF1A promoter hypermethylation in serum DNA is a non-invasion prognostic biomarker for early recurrence of hepatocellular carcinoma after curative resection $f Z. J. Liu ... [et al.] 215 $c ilustr., grafy, tab. 320 $a Bibliogr. odkazy 463 -1
$1 001 sllk_un_cat*0139782 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 64, no. 5 (2017), s. 795-802 $1 210 $a Bratislava $c AEPress $d 2017 $1 215 $a s. 641-808 541 1-
$a Kombinácia hypometylácie LINE-1 a hypermetylácie promótora RASSF1A DNA v sére je neinvazívny, prognostický biomarker pre včasnú recidívu hepatocelulárneho karcinómu po kuratívnej resekcii $z slo 606 1-
$3 sllk_un_auth*d006528 $a karcinóm hepatocelulárny $x chirurgia $x genetika $x krv $2 mesh 606 1-
$3 sllk_un_auth*d016147 $a gény supresorové nádorové $2 mesh 606 2-
$3 sllk_un_auth*d011401 $a oblasti promótorové, v genetike $2 mesh 606 1-
$3 sllk_un_auth*d019175 $a metylácia DNA $2 mesh 606 2-
$3 sllk_un_auth*d009364 $a recidíva nádoru, lokálna $2 mesh 606 2-
$3 sllk_un_auth*d014408 $a biomarkery nádorové $2 mesh 606 2-
$3 sllk_un_auth*d016019 $a analýza prežívania $2 mesh 606 2-
$3 sllk_un_auth*d011379 $a prognóza $2 mesh 610 2-
$a LINE-1 hypometylácia 610 2-
$a RASSF1A hypermetylácia 701 -1
$3 sllk_un_auth*0044467 $a Liu $b Z. J. $4 070 801 -0
$a SK $b BA006 $c 20171030 $g AACR2
Number of the records: 1